← FDA ENFORCEMENT
D-0626-2026Class II

Annora Pharma Private Limited

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
Annora Pharma Private Limited
Product type
Drug
Status
Ongoing
Report date
2026-07-01
Distribution
Nationwide in the USA
Firm state
N/A
Product quantity
31,392 60-count bottles
Initiated by
Voluntary: Firm initiated
Reason for recall

Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.

Product description

Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.

Code / lot info

Lot: A253999, A254000, Expires: 09/30/2027.

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →